Japanese medical technology firm CureApp is getting 7 billion yen ($51.4 million) in investment from global investment firm Carlyle as part of their strategic partnership.
Carlyle is taking a minority stake in the company, which has so far raised 13.4 billion yen ($98 million) in capital funding.
Founded in 2014, CureApp is involved in the research and development of prescription and non-...
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills.
In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from insomnia.
It adds that the app could save the NHS money and reduce prescriptions of medicines such as...
Japan's Ministry of Health, Labour and Welfare has awarded the Japanese medtech startup CureApp a medical device regulatory approval for its digital therapeutic app for hypertension.
WHAT IT DOES
CureApp's latest DTx app assists patients in maintaining lifestyle improvements as part of their treatment for hypertension. It automatically delivers personalised guidance to users, including advice on...
KT Corporation, one of South Korea's biggest telecommunications firms, has signed a memorandum of understanding with the Catholic Medical Center of the Catholic University of Korea to jointly develop digital treatment devices.
WHAT IT'S ABOUT
Under the agreement, the companies will jointly cooperate to develop a platform to create digital therapeutics (DTx) devices and build prototypes. They will...
As 2021 draws to a close, MobiHealthNews consults experts across the EMEA region to find out their vision for the year ahead in digital health.
Filippo Falaschi, investor, digital health and med tech investment management firm Spex Capital
There’s no doubt the pandemic served as a major catalyst in the development and adoption of digital health technologies at speed and scale. Investment figures...
Pear Therapeutics is looking to enter the depression space with the acquisition of fellow digital-therapeutic company Waypoint Health Innovations’ assets, as well as the assets of Örebro University researcher Fredrik Holländare.
“The addition of these depression assets to our portfolio fits squarely in our near-term focus to expand our leadership in psychiatry. With these deals, we have the...
Japanese medical device maker Jolly Good and the Pain Center at the Aichi Medical University Hospital will conduct a study on the efficacy of virtual reality-based therapy for chronic pain.
It was in April last year that Jolly Good set up its digital therapeutics division, which involves a team of psychiatrists, pharmaceutical strategy specialists, and other DTx specialists. Through this, the...
China-based biopharmaceutical firm AffaMed Therapeutics has established its digital medicines subsidiary, AffaMed Digital.
Based on a press release, the newly formed unit will focus on developing and marketing evidence-based, clinically validated digital medicines to treat, diagnose, prevent and manage medical disorders or diseases, either as stand-alone novel treatment options or alongside...
Sumitomo Dainippon Pharma Co. in Japan and US-based behavioural health firm BehaVR have signed definitive agreements to develop and market general wellness products and prescription digital therapeutics for the treatment of major mental health disorders.
WHAT IT'S ABOUT
Sumitomo Dainippon Pharma is engaged in the research and development of new pharmaceutical products in the areas of psychiatry...
A landmark clinical trial has found that a new digital therapeutic app for hypertension is effective in reducing the risks of cardiovascular and cerebrovascular diseases.
Japanese medical technology startup CureApp collaborated with Jichi Medical University in the Tochigi Prefecture to conduct the third phase of the said clinical trial, which marks the world's first trial of a therapeutic app for...
_5.jpeg?itok=OM4zn-f1)
